Literature DB >> 6498073

Prognostic significance of peritumoral vascular invasion in breast cancer.

R Bettelheim, H G Penman, H Thornton-Jones, A M Neville.   

Abstract

A prospective study of 232 patients with primary invasive breast cancer (UICC Stages I, II and III) and histologically confirmed axillary node status was carried out to assess the prognostic significance of several readily available clinical and pathological characteristics. In addition to the recognised utility of tumour size and axillary lymph node status, the presence or absence of cohesive clumps of malignant cells in peritumoral vascular spaces (both lymphatic and blood vessels) was found to be prognostically important.

Entities:  

Mesh：

Year:  1984        PMID： 6498073      PMCID： PMC1977004          DOI： 10.1038/bjc.1984.255

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  13 in total

1.  Lymphatic and vascular channel involvement within infiltrative breast carcinomas as a guide to prognosis at the time of primary surgical treatment.

Authors:  R Bettelheim; A M Neville
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

2.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

3.  Re-evaluation of blood-vessel invasion as a prognostic factor in carcinoma of the breast.

Authors:  S J Kister; S C Sommers; C D Haagensen; E Cooley
Journal:  Cancer       Date:  1966-09       Impact factor: 6.860

4.  Oestrogen receptor assay and morphology of breast cancer.

Authors:  A N Roberts; R Hähnel
Journal:  Pathology       Date:  1981-04       Impact factor: 5.306

5.  Predictors of recurrence in stage I (T1N0M0) breast carcinoma.

Authors:  P P Rosen; P E Saigo; D W Braun; E Weathers; A DePalo
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

6.  Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma.

Authors:  F A Nime; P P Rosen; H T Thaler; R Ashikari; J A Urban
Journal:  Am J Surg Pathol       Date:  1977-03       Impact factor: 6.394

7.  The influence of pathologic factors on breast cancer management.

Authors:  R V Hutter
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

8.  Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer.

Authors:  T J Powles; R C Coombes; I E Smith; J M Jones; H T Ford; J C Gazet
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

9.  Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli.

Authors:  P P Rosen; P E Saigo; D W Braun; E J Beattie; D W Kinne
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

10.  The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections.

Authors:  J P Sloane; M G Ormerod; S F Imrie; R C Coombes
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640
View more
  14 in total

1.  Peritumoral lymphatic vessel invasion compared with DNA ploidy, proliferative activity, and other pathologic features as prognostic indicators in operable breast cancer.

Authors:  G Gasparini; S Meli; G A Panizzoni; A Visonà; P Boracchi; P Bevilacqua; E Marubini; F Pozza
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

2.  Axl receptor tyrosine kinase expression in breast cancer.

Authors:  Timothy M D'Alfonso; Jeffrey Hannah; Zhengming Chen; Yifang Liu; Pengbo Zhou; Sandra J Shin
Journal:  J Clin Pathol       Date:  2014-06-05       Impact factor: 3.411

3.  Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers.

Authors:  C Gajdos; P I Tartter; I J Bleiweiss
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

4.  Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.

Authors:  Mariko Asaoka; Santosh K Patnaik; Frank Zhang; Takashi Ishikawa; Kazuaki Takabe
Journal:  Breast Cancer Res Treat       Date:  2020-04-13       Impact factor: 4.872

5.  Vascular invasion in non-small cell lung carcinoma.

Authors:  T E Roberts; P S Hasleton; C Musgrove; R Swindell; R A Lawson
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

6.  Current status of diagnosis and treatment of primary breast cancer in beijing, 2008.

Authors:  Xiao-Mei Yuan; Ning Wang; Tao Ouyang; Lei Yang; Ming-Yang Song; Ben-Yao Lin; Yun-Tao Xie; Jin-Feng Li; Kai-Feng Pan; Wei-Cheng You; Lian Zhang
Journal:  Chin J Cancer Res       Date:  2011-03       Impact factor: 5.087

7.  Characteristics of patients with short and long survivals after detection of intracranial metastases from breast cancer.

Authors:  C Kamby; P S Soerensen
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

8.  Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.

Authors:  J L Mansi; U Berger; D Easton; T McDonnell; W H Redding; J C Gazet; A McKinna; T J Powles; R C Coombes
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-31

9.  Prognostic Role of Lymphovascular Invasion in Patients with Early Breast Cancer.

Authors:  M Akrami; A Meshksar; Johari M Ghoddusi; M M Safarpour; S Tahmasebi; V Zangouri; A Talei
Journal:  Indian J Surg Oncol       Date:  2021-08-26

10.  Body weight and vascular invasion in post-menopausal women with breast cancer.

Authors:  R A Badwe; I S Fentiman; R R Millis; W M Gregory
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.